期刊文献+

心肌钙蛋白I在杆状病毒表达系统中的表达 被引量:1

Expression of cardiac troponin I in baculovirus system
原文传递
导出
摘要 目的在杆状病毒表达系统中表达心肌钙蛋白(Icardiac troponin I,cTnI)。方法将带有6×His标签的cTnI基因亚克隆至杆状病毒转移载体pFastBac-dua(lpFBd)中,构建重组转移质粒pFBd-cTnI,转化大肠埃希菌DH10-Bac,筛选获得重组杆粒rbacmid-cTnI,转染昆虫细胞Sf9,SDS-PAGE和Western blot检测转染细胞中cTnI蛋白的表达。结果重组杆粒rbacmid-cTnI经PCR鉴定证明构建正确;重组杆粒rbacmid-cTnI转染的Sf9细胞(Invitrogen细胞株)可表达相对分子质量约25 000的cTnI蛋白条带,表达的cTnI蛋白可被鼠抗His标签单抗和兔抗cTnI多抗特异性识别。结论成功在Sf9细胞中表达了cTnI蛋白,为下一步大规模制备cTnI蛋白以及建立cTnI相关检测方法奠定了基础。 Objective To express cardiac troponin I (cTnI) in baculovirus system. Methods The cTnI gene with 6 x His tag was subcloned to baculovirus transfer vector pFastBac-dual (pFBd). The constructed recombinant transfer plasmid pFBd-cTnI was transformed to competent E. coli DHIOBac, based on which recombinant bacmid rbacmid-cTnI was screened and transfected to Sf9 cells. The expression of cTnI protein was determined by SDS-PAGE and Western blot. Results PCR proved that rbacmid-cTnI was constructed correctly. The cTnI protein, with a relative molecular mass of about 25 000, was expressed in Invitrogen straion of Six) cells transfeeted with rbacmid-cTnI, and was recognized by mouse monoclonal antibody against His tag and rabbit polyelonal antibody against cTnI. Conclusion The cTnI protein was successfully expressed in Sf9 cells, which laid a foundation of further preparation of cTnI protein and development of test method for cTnI.
出处 《中国生物制品学杂志》 CAS CSCD 2013年第9期1232-1236,共5页 Chinese Journal of Biologicals
关键词 心肌钙蛋白Ⅰ 杆状病毒 SF9细胞 Cardiac troponin I (cTnI) Baculovirus Sf9 cells
  • 相关文献

参考文献8

二级参考文献156

  • 1曾玲,蒋薇.免疫增强比浊法测定肌钙蛋白I的方法学评价[J].湖南师范大学学报(医学版),2005,2(4):47-48. 被引量:1
  • 2王忠诚,沈钧乐,王强,府伟灵.心肌肌钙蛋白I的检测方法及临床应用进展[J].国外医学(临床生物化学与检验学分册),2004,25(4):303-305. 被引量:28
  • 3潘柏申.心脏标志物的临床应用[J].中华检验医学杂志,2005,28(1):124-126. 被引量:62
  • 4吴铁吉.病毒性心肌炎诊断标准(修订草案)[J].中华儿科杂志,2000,38(2):75-75.
  • 5Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined aconsensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol,2000,36: 959-969.
  • 6Wu AH, Apple FS, Gibler WB, et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice : recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem ,1999,45:1104-1121.
  • 7Fitzmaurice TF, Brown C, Rifai N, et al. False increase of cardiac troponin Ⅰ with heterophilic antibodies. Clin Chem, 1998, 44:2212-2214.
  • 8Krahn J, Parry DM, Leroux M, et al. High percentage of false positive cardiac tropenin Ⅰ results in patients with rheumatoid factor. Clin Biochem, 1999,32:477-480.
  • 9Plebani M, Mion M, Ahinier S, et al. False-positive troponin Ⅰ attributed to a macrocomplex. Clin Chem, 2002,48:677-679.
  • 10Lagneau F, Beyne P, Letteron P, et al. Fluid therapy directly interferes with immunoassay for cardiac troponin I. Intensive Care Med, 1999,25:625-627.

共引文献111

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部